Paper29338689
Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
Park JS and 7 others. BMC Cancer, 2018. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. Papers, record 29338689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29338689
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BRCA1 Protein | Major topic |
| BRCA2 Protein | Major topic |
| Breast Neoplasms | Major topic |
| Hereditary Breast and Ovarian Cancer Syndrome | Major topic |
| Adult | |
| Aged | |
| Fanconi Anemia Complementation Group N Protein | |
| Fanconi Anemia Complementation Group Proteins | |
| Female | |
| Genetic Predisposition to Disease | |
| Germ-Line Mutation | |
| Humans | |
| MRE11 Homologue Protein | |
| Middle Aged | |
| RNA Helicases | |
| Risk Factors | |
| Tumor Suppressor Protein p53 | |
| Tumor Suppressor Proteins | |
| Ubiquitin-Protein Ligases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KBCF-2015E002 | Korea Breast Cancer Foundation | International | PubMed | |
| 2016R1D1A1B03934564 | National Research Foundation of Korea | International | PubMed |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29263802 | Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. | NPJ Genom Med | 2016 | https://conductscience.org/library/papers/29263802 | PubMed |
| 2 | 22942019 | A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22942019 | PubMed |
| 3 | 19633669 | Role of mammalian Mre11 in classical and alternative nonhomologous end joining. | Nat Struct Mol Biol | 2009 | https://conductscience.org/library/papers/19633669 | PubMed |
| 4 | 26921362 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. | J Med Genet | 2016 | https://conductscience.org/library/papers/26921362 | PubMed |
| 5 | 29338689 | Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29338689 | PubMed |
| 6 | 26681312 | Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. | Genet Med | 2016 | https://conductscience.org/library/papers/26681312 | PubMed |
| 7 | 26014596 | Gene-panel sequencing and the prediction of breast-cancer risk. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26014596 | PubMed |
| 8 | 25467110 | Beyond BRCA: new hereditary breast cancer susceptibility genes. | Cancer Treat Rev | 2015 | https://conductscience.org/library/papers/25467110 | PubMed |
| 9 | 26436112 | Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. | Mol Genet Genomic Med | 2015 | https://conductscience.org/library/papers/26436112 | PubMed |
| 10 | 28418444 | Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28418444 | PubMed |
| 11 | 26790966 | Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. | Cancer Res Treat | 2016 | https://conductscience.org/library/papers/26790966 | PubMed |
| 12 | 25186627 | Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. | Cancer | 2015 | https://conductscience.org/library/papers/25186627 | PubMed |
| 13 | 25503501 | Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. | Genet Med | 2015 | https://conductscience.org/library/papers/25503501 | PubMed |
| 14 | 24733792 | Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24733792 | PubMed |
| 15 | 18484200 | Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. | Adv Ther | 2008 | https://conductscience.org/library/papers/18484200 | PubMed |
| 16 | 18381420 | Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. | Cancer Res | 2008 | https://conductscience.org/library/papers/18381420 | PubMed |
| 17 | 17606709 | Transcriptional functionality of germ line p53 mutants influences cancer phenotype. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17606709 | PubMed |
| 18 | 18175216 | The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. | Breast Cancer Res Treat | 2008 | https://conductscience.org/library/papers/18175216 | PubMed |
| 19 | 26787654 | Multigene testing of moderate-risk genes: be mindful of the missense. | J Med Genet | 2016 | https://conductscience.org/library/papers/26787654 | PubMed |
| 20 | 25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 | https://conductscience.org/library/papers/25741868 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40167152 | Germline variants analysis of Chinese breast cancer patients reveals numerous alterations in homologous recombination genes. | Future Sci OA | 2025 | https://conductscience.org/library/papers/40167152 | PubMed |
| 39409938 | Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409938 | PubMed |
| 39272924 | Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39272924 | PubMed |
| 38935898 | Hereditary Cancer Screening and Outcomes at an Urban Safety-Net Hospital. | JCO Precis Oncol | 2024 | https://conductscience.org/library/papers/38935898 | PubMed |
| 35785170 | Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | https://conductscience.org/library/papers/35785170 | PubMed |
| 34545504 | Outcomes of retesting in patients with previously uninformative cancer genetics evaluations. | Fam Cancer | 2022 | https://conductscience.org/library/papers/34545504 | PubMed |
| 33637119 | Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia. | Hered Cancer Clin Pract | 2021 | https://conductscience.org/library/papers/33637119 | PubMed |
| 33114377 | BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/33114377 | PubMed |
| 32888145 | Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population. | Breast Cancer | 2021 | https://conductscience.org/library/papers/32888145 | PubMed |
| 32761968 | Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32761968 | PubMed |
| 32726901 | Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32726901 | PubMed |
| 32679805 | Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32679805 | PubMed |
| 31650731 | Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome. | Ann Lab Med | 2020 | https://conductscience.org/library/papers/31650731 | PubMed |
| 30309218 | Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan. | Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30309218 | PubMed |
| 30262796 | Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30262796 | PubMed |
| 29338689 | Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29338689 | PubMed |
Genes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29338689
GET https://conductscience.org/api/papers/v1/29338689/references?page=2